Thursday, September 16TRUSTED FEARLESS INTERNATIONAL & NATIONAL NEWS PORTAL

Covid-19: Panel for nod to P-2/3 vaccine trials for 2-17-year-olds | India News – Times of India


NEW DELHI: An expert panel of India’s Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India for conducting phase 2/3 trials of Covid vaccine Covovax on kids aged 2 to 17 years with certain conditions, official sources said. The trials would cover 920 children, 460 each in the age-group of 12-17 and 2-11 across 10 sites.
“The Subject Expert Committee on Covid-19 deliberated on the revised study protocol application given by SII on Tuesday and recommended granting permission to the firm for conducting phase 2/3 trial of Covovax on kids aged 2 to 17 years,” a source said.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *